Joana Correia | Executive Director And Chief Scientific Officer
Exogenus Therapeutics

Joana Correia, Executive Director And Chief Scientific Officer, Exogenus Therapeutics

Joana Correia is graduated in Chemistry by the University of Coimbra and a PhD in Human Biology by the University of Porto and the Flanders Institute of Biotechnology. She was a researcher in several renowned R&D institutions worldwide and published several high impact papers such as in Human Molecular Genetics, PNAS and Gut. She was an Assistant Investigator in the Center for Neurosciences and Cell Biology of the University of Coimbra since 2014. 
Joana participated in the Technology Transfer program COHiTEC in 2014, and together with two partners, founded Exogenus Therapeutics in 2015, assuming the roles of Executive Director and Chief Scientific Officer. Since then, she has been distinguished with the 17th Edition of the Young Entrepreneur Award (2015), by the Portuguese Association of Young Entrepreneurs (ANJE) and the Young Transatlantic Innovation Leader 2017, an international program organized by the US government through the German Marshall Fund of US. She has won the Best Pitch presentation at the Startup Slam competition in Bio Europe Autumn 2017, the 2nd place at the Venture Lounge 2017 competition in Darmstadt (Life Sciences and Medtech, organized by H2020 SME Instrument Business Acceleration Services), and was a finalist Wound Care Innovation Award 2017 (at the EWMA- European Wound Management Association conference). Under her leadership, Exogenus Therapeutics won the international Everis Foundation Award in 2016, was distinguished with the SME Instrument Phase I and Seal of Excellence in Phase II, from the European Commission, and was recently selected as one of the top-500 deeptech startups recognized worldwide by the Hello Tomorrow Global Challenge.

Appearances:



Conference Day 2: Friday 17th May 2019 @ 10:00

Therapeutic potential of UCB-derived extracellular vesicles

  • Clinical use of Extracellular vesicles: Opportunities and Threats
  • How to go from UCB to a GMP-compliant product based in extracellular vesicles for Clinical application
  • Therapeutic potential of Exogenus Therapeutics’ proprietary small extracellular vesicles
  • Pipeline development and future Roadmap
last published: 14/May/19 13:35 GMT

back to speakers

The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.

Register your pass here.